Fingerprint
Dive into the research topics of 'CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer
Jorge Franco, Agnieszka K. Witkiewicz, Erik S. Knudsen
Research output: Contribution to journal › Article › peer-review
170
Scopus
citations